Enlivex Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 2.21 M | $2.58 M | 3.23% | 10.38% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 633,847 | $741,601 | 100.00% | 2.98% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 158,992 | $186,021 | 112.59% | 0.75% |
| SIGMA INVESTMENT COUNSELORS INC | 02/04/2025 | 28,000 | $32,760 | -6.67% | 0.13% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 22,362 | $26,164 | 100.00% | 0.11% |
| HRT FINANCIAL LP | 02/14/2025 | 16,878 | $19,000 | 100.00% | 0.08% |
| JANE STREET GROUP, LLC | 02/14/2025 | 12,873 | $15,061 | 100.00% | 0.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 11,159 | $13,056 | 100.00% | 0.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 10,420 | $12,191 | 0.00% | 0.05% |
| ARS WEALTH ADVISORS GROUP, LLC | 01/14/2025 | 10,000 | $11,700 | 100.00% | 0.05% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 9,184 | $10,745 | 0.00% | 0.04% |
| SIGNATUREFD, LLC | 02/10/2025 | 5,000 | $5,850 | 66.67% | 0.02% |
| SIMPLEX TRADING, LLC | 02/11/2025 | 3,366 | $3,000 | 100.00% | 0.02% |
| JPMORGAN CHASE & CO | 02/12/2025 | 2,564 | $3,000 | 41.35% | 0.01% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/06/2025 | 2,500 | $2,925 | -16.67% | 0.01% |
| SRS CAPITAL ADVISORS, INC. | 02/05/2025 | 1,015 | $1,188 | 65.04% | 0.00% |
| BFSG, LLC | 01/31/2025 | 1,000 | $1,170 | 100.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 01/28/2025 | 1,000 | $1,170 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 709 | $1,034 | 77.25% | 0.00% |
| SPIRE WEALTH MANAGEMENT | 01/24/2025 | 500 | $585 | 100.00% | 0.00% |
| RED TORTOISE LLC | 01/24/2025 | 150 | $176 | 0.00% | 0.00% |
| UBS GROUP AG | 02/14/2025 | 16 | $19 | -99.50% | 0.00% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 01/31/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enlivex Therapeutics Ltd. institutional Ownership - FAQ's
During the previous two years, 31 institutional investors and hedge funds held shares of Enlivex Therapeutics Ltd.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 2.21 M
MILLENNIUM MANAGEMENT LLC: 633,847
RENAISSANCE TECHNOLOGIES LLC: 158,992
SIGMA INVESTMENT COUNSELORS INC: 28,000
TWO SIGMA SECURITIES, LLC: 22,362
HRT FINANCIAL LP: 16,878
16.03% of Enlivex Therapeutics Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 3.40 M shares in the last 24 months. This purchase volume represents approximately $4.18 M in transactions.